Evidence map›Paper›PMID 26792028›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2017

White matter hyperintensity microstructure in amyloid dysmetabolism.

Lisa F Kalheim, Atle Bjørnerud, Tormod Fladby, Kjetil Vegge, Per Selnes

Abstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Deep medullary veins are associated with widespread brain structural abnormalities.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  12. Decreased visible deep medullary veins is a novel imaging marker for cerebral small vessel disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
  13. Article
  14. Metabolic Syndrome and Amyloid Accumulation in the Aging Brain.Journal of Alzheimer's disease : JAD · 2018
    Article
  15. Article
  16. Article
  17. Advanced Neuroimaging of Cerebral Small Vessel Disease.Current treatment options in cardiovascular medicine · 2017
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lisa F KalheimDepartment of Neurology, Akershus University Hospital, Lørenskog, Norway Lisa.Flem.Kalheim@ahus.no.
Atle BjørnerudThe Intervention Centre, Oslo University Hospital, Oslo, Norway.
Tormod FladbyDepartment of Neurology, Akershus University Hospital, Lørenskog, Norway.
Kjetil VeggeDepartment of Radiology, Akershus University Hospital, Lørenskog, Norway.
Per SelnesDepartment of Neurology, Akershus University Hospital, Lørenskog, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence suggests associations between cerebrovascular disease (CVD) and Alzheimer's disease (AD). White matter hyperintensities of presumed vascular origin (WMHs) are increased in subjects with mild cognitive impairment (MCI) and AD, but the exact pathomechanistic link is unknown. The current study investigated effects of amyloid dysmetabolism on the microstructure of WMHs in subjects with MCI or subjective cognitive decline (N = 51), dichotomized according to pathological or normal levels of amyloid-β peptide (Aβ

Indexed as

Alzheimer DiseaseCerebrovascular DisordersAgedAmyloidAmyloid beta-PeptidesAmyloidogenic ProteinsAnisotropyCase-Control StudiesDemyelinating DiseasesDiffusion Magnetic Resonance ImagingDiffusion Tensor ImagingHumansMiddle AgedWhite MatterAmyloidAmyloid beta-PeptidesAmyloidogenic ProteinsAlzheimer’scerebrospinal fluidcognitive impairmentdiffusion tensor imagingwhite matter disease

Identifiers

PMID26792028
PMCPMC5363752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.